MA53673A - Procédé de production d'un dérivé de 4-méthoxy pyrrole - Google Patents

Procédé de production d'un dérivé de 4-méthoxy pyrrole

Info

Publication number
MA53673A
MA53673A MA053673A MA53673A MA53673A MA 53673 A MA53673 A MA 53673A MA 053673 A MA053673 A MA 053673A MA 53673 A MA53673 A MA 53673A MA 53673 A MA53673 A MA 53673A
Authority
MA
Morocco
Prior art keywords
production
pyrrole derivative
methoxy pyrrole
methoxy
derivative
Prior art date
Application number
MA053673A
Other languages
English (en)
Inventor
Deok Ki Eom
Jeong Taek Shin
Jeong Hyun Son
Original Assignee
Daewoong Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daewoong Pharmaceutical Co Ltd filed Critical Daewoong Pharmaceutical Co Ltd
Publication of MA53673A publication Critical patent/MA53673A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
MA053673A 2018-09-19 2019-09-19 Procédé de production d'un dérivé de 4-méthoxy pyrrole MA53673A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20180112196 2018-09-19
KR1020190110997A KR102126576B1 (ko) 2018-09-19 2019-09-06 4-메톡시 피롤 유도체의 제조 방법

Publications (1)

Publication Number Publication Date
MA53673A true MA53673A (fr) 2022-03-30

Family

ID=69959291

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053673A MA53673A (fr) 2018-09-19 2019-09-19 Procédé de production d'un dérivé de 4-méthoxy pyrrole

Country Status (21)

Country Link
US (1) US12110271B2 (fr)
EP (1) EP3854784B1 (fr)
JP (1) JP7253624B2 (fr)
KR (1) KR102126576B1 (fr)
CN (1) CN112739684B (fr)
AU (1) AU2019343857B2 (fr)
BR (1) BR112021005156A2 (fr)
CL (1) CL2021000639A1 (fr)
CO (1) CO2021003195A2 (fr)
DO (1) DOP2021000042A (fr)
EC (1) ECSP21019076A (fr)
JO (1) JOP20210040A1 (fr)
MA (1) MA53673A (fr)
MX (1) MX2021003137A (fr)
MY (1) MY205351A (fr)
PE (1) PE20211736A1 (fr)
PH (1) PH12021550523A1 (fr)
RU (1) RU2763287C1 (fr)
SA (1) SA521421372B1 (fr)
SG (1) SG11202101919VA (fr)
TN (1) TN2021000035A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102081920B1 (ko) 2016-03-25 2020-02-26 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민 염의 신규한 결정형
KR102233455B1 (ko) * 2017-06-21 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
KR102126576B1 (ko) 2018-09-19 2020-06-24 주식회사 대웅제약 4-메톡시 피롤 유도체의 제조 방법
DK4245298T3 (en) 2020-12-18 2026-03-30 Daewoong Pharmaceutical Co Ltd Hidtil ukendt formulering til oral administration, som omfatter 1-(5-(2,4-difluorphenyl)-1-((3-fluorphenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n-methylmethanamin
KR102556500B1 (ko) * 2021-11-19 2023-07-19 하나제약 주식회사 피롤 유도체 또는 이의 약학적 또는 식품학적으로 허용 가능한 염, 및 이를 유효성분으로 포함하는 위장 질환의 예방, 개선 또는 치료용 조성물
WO2023229323A1 (fr) * 2022-05-23 2023-11-30 일동제약(주) Procédé de préparation d'un dérivé de 6-méthoxypyridin-3-yle
CN119365448A (zh) * 2022-05-23 2025-01-24 日东制药株式会社 一种6-甲氧基吡啶-3-基衍生物的制备方法
CN117820193A (zh) * 2022-09-29 2024-04-05 安徽皓元药业有限公司 一种非苏拉赞盐酸盐晶型a及其制备方法
KR102938657B1 (ko) 2023-02-15 2026-03-12 주식회사 대웅제약 4-메톡시 피롤 유도체의 제조 방법
WO2025023734A1 (fr) * 2023-07-26 2025-01-30 Yunovia Co., Ltd. Procédé de préparation d'intermédiaires de dérivés de 6-méthoxypyridine-3-yle

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1592996A (en) 1977-10-10 1981-07-15 Rolland Sa A Acylated pyrrole carboxylic acids and derivatives thereof
SK287857B6 (sk) 2001-05-24 2012-01-04 Eli Lilly And Company Novel pyrrole derivatives as pharmaceutical agents
WO2004026828A1 (fr) 2002-09-20 2004-04-01 Lupin Limited Derives de pyrrole servant de composes anti-mycobacteriens
KR101178747B1 (ko) * 2004-09-30 2012-09-03 다케다 야쿠힌 고교 가부시키가이샤 프로톤 펌프 저해제
PE20070540A1 (es) 2005-08-30 2007-06-26 Takeda Pharmaceutical Derivados de pirrol como inhibidores de la secrecion acida
WO2007114338A1 (fr) * 2006-03-31 2007-10-11 Takeda Pharmaceutical Company Limited Inhibiteur de secretion d'acide
EP2041085A1 (fr) 2006-06-27 2009-04-01 Abbott Laboratories Dérivés de pyrrole et leurs procédés d'utilisation
US8933105B2 (en) 2007-02-28 2015-01-13 Takeda Pharmaceutical Company Limited Pyrrole compounds
WO2009137657A1 (fr) 2008-05-08 2009-11-12 Bristol-Myers Squibb Company Dérivés du 2-arylglycinamide
TW201431552A (zh) 2008-07-28 2014-08-16 Takeda Pharmaceutical 醫藥組成物
UA105185C2 (uk) 2008-08-27 2014-04-25 Такеда Фармасьютікал Компані Лімітед Піроли
KR101318690B1 (ko) 2008-10-02 2013-10-16 주식회사 녹십자 우울 장애 치료용 아릴피페라진-함유 피롤 3-카복스아미드 유도체
GB0823003D0 (en) 2008-12-17 2009-01-28 Syngenta Participations Ag Pyrrole derivatives with plant growth regulating properties
CA2891523A1 (fr) 2012-11-19 2014-05-22 Jiangsu Hansoh Pharmaceutical Co., Ltd. Derive pyrrole sulfonamide, procede de preparation et application medicale associes
CN105164105B (zh) 2013-04-10 2018-01-30 第一三共株式会社 吡咯衍生物的结晶及其制备方法
JP2017071553A (ja) 2014-02-25 2017-04-13 味の素株式会社 ヘテロ原子−メチレン−ヘテロ環構造を有する新規化合物
CN104447491B (zh) * 2014-11-19 2017-06-23 连云港恒运医药有限公司 含吡咯环质子泵抑制剂的半富马酸盐及其中间体和医药用途
KR101613245B1 (ko) * 2015-04-27 2016-04-18 주식회사 대웅제약 신규의 4-메톡시 피롤 유도체 또는 이의 염 및 이를 포함하는 약학 조성물
CN106432191A (zh) * 2015-08-10 2017-02-22 陕西合成药业股份有限公司 一种新的吡咯类衍生物、其制备方法及其在医药上的应用
WO2017164575A1 (fr) * 2016-03-25 2017-09-28 Daewoong Pharmaceutical Co.,Ltd. Nouveau sel d'addition d'acide de 1-(5-(2,4-difluorophényl)-1-((3-fluorophényl)sulfonyl)-4-méthoxy-1h-pyrrol-3-yl)-n-méthylméthanamine
KR102081920B1 (ko) 2016-03-25 2020-02-26 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민 염의 신규한 결정형
KR20170113040A (ko) 2016-03-25 2017-10-12 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민의 신규한 산부가염
CN107879964B (zh) * 2016-09-29 2023-02-10 江苏柯菲平医药股份有限公司 1-(5-(2-氟苯基)-1-(3-(3-甲氧丙氧基)苯磺酰氯)-1h-吡咯-3-基)-n-甲基胺的制备方法
KR102233456B1 (ko) 2017-05-31 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
KR102233455B1 (ko) 2017-06-21 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
CN108503621B (zh) * 2017-12-25 2021-09-14 上海中拓医药科技有限公司 一种富马酸沃诺拉赞的制备方法
KR102126576B1 (ko) 2018-09-19 2020-06-24 주식회사 대웅제약 4-메톡시 피롤 유도체의 제조 방법
WO2020060213A1 (fr) 2018-09-19 2020-03-26 주식회사 대웅제약 Procédé de production d'un dérivé de 4-méthoxy pyrrole
TN2023000270A1 (en) 2021-05-26 2025-07-02 Daewoong Pharmaceutical Co Ltd Medicine container containing liquid pharmaceutical composition of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n-methylmethanamine

Also Published As

Publication number Publication date
KR20200033178A (ko) 2020-03-27
AU2019343857A1 (en) 2021-04-15
KR102126576B1 (ko) 2020-06-24
US12110271B2 (en) 2024-10-08
US20210221770A1 (en) 2021-07-22
CN112739684A (zh) 2021-04-30
TN2021000035A1 (en) 2022-10-03
CO2021003195A2 (es) 2021-04-08
JOP20210040A1 (ar) 2021-03-07
CA3110830A1 (fr) 2020-03-26
MX2021003137A (es) 2021-05-14
BR112021005156A2 (pt) 2021-06-15
ECSP21019076A (es) 2021-05-31
PE20211736A1 (es) 2021-09-06
AU2019343857B2 (en) 2021-12-02
PH12021550523A1 (en) 2022-02-21
NZ773997A (en) 2024-03-22
EP3854784A4 (fr) 2022-03-30
EP3854784B1 (fr) 2026-04-15
CN112739684B (zh) 2024-06-04
SG11202101919VA (en) 2021-04-29
RU2763287C1 (ru) 2021-12-28
JP7253624B2 (ja) 2023-04-06
JP2021535934A (ja) 2021-12-23
MY205351A (en) 2024-10-17
EP3854784A1 (fr) 2021-07-28
SA521421372B1 (ar) 2024-01-25
DOP2021000042A (es) 2021-05-31
CL2021000639A1 (es) 2021-08-06

Similar Documents

Publication Publication Date Title
EP3854784A4 (fr) Procédé de production d'un dérivé de 4-méthoxy pyrrole
EP3693373A4 (fr) Procédé pour la production stéréosélective d'un dérivé de pyridone polycyclique substitué
EP3473621A4 (fr) Procédé de production d'un dérivé de diphénylméthane
MA50169A (fr) Procédé de production d'un électrocatalyseur
EP3702121A4 (fr) Procédé de production d'un objet moulé en céramique
EP3318551A4 (fr) Procédé de production d'un composé pyrrole
EP3392236A4 (fr) Procédé de production d'un dérivé amide aromatique
EP3588654A4 (fr) Procédé de production d'une monocellule
EP3653635A4 (fr) Procédé de production d'un intermédiaire herbicide
EP4023804A4 (fr) Procédé de production d'articles fibreux
EP3768487C0 (fr) Procédé de micromoulages d'articles
EP4375273A4 (fr) Procédé de production d'un dérivé arylamide
EP3995475A4 (fr) Procédé de production de 1,3-butadiène
EP3677572A4 (fr) Procédé de production d'un dérivé de pyrazole-4-carboxamide
EP3778560A4 (fr) Procédé de production d'acrylonitrile
EP4079755A4 (fr) Procédé de production d'organoïde
EP3808261A4 (fr) Procédé de production d'une bioélectrode
EP3858886A4 (fr) Procédé de production d'un composé polymère
EP3778687A4 (fr) Procédé de production d'une composition polymérisable
EP3789493A4 (fr) Procédé de production de cello-oligosaccharides
EP3663343A4 (fr) Procédé de production d'un objet poreux
EP4001280A4 (fr) Procédé de production d'un dérivé du phénol
EP3932933A4 (fr) Procédé de production d'amide
EP3831803A4 (fr) Procédé de production de 1,3-bisacyloxy-2-méthylène propane
EP3881848A4 (fr) Procédé de production d'un dérivé d'acide orotique